PCWA
TRAW icon

Pacific Capital Wealth Advisors’s Traws Pharma TRAW Stock Holding History

Pacific Capital Wealth Advisors’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2
Closed -$18 – 399
2024
Q4 		$18 Hold
2
– – ﹤0.01% 395
2024
Q3 		$12 Sell
2
-1
-33% -$9 ﹤0.01% 488
2024
Q2 		$29 Buy
+3
New +$48 ﹤0.01% 526

Other funds holding TRAW

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacific Capital Wealth Advisors's TRAW Position: Q1 2025 in Review

Pacific Capital Wealth Advisors sold out of Traws Pharma (TRAW) in Q1 2025, closing a stake of 2 shares — an estimated $18 sold.

Pacific Capital Wealth Advisors first reported a position in TRAW in Q2 2024 and held it in 3 quarters. The position peaked at $29 in Q2 2024. 19 funds tracked by Wall St. Rank hold TRAW as of Q1 2025.

  • Pacific Capital Wealth Advisors reported no remaining Traws Pharma position as of Q1 2025 after selling out during the quarter.
  • Pacific Capital Wealth Advisors sold 2 Traws Pharma shares in Q1 2025, an estimated $18.
  • Pacific Capital Wealth Advisors first reported a position in Traws Pharma in Q2 2024 and held it in 3 quarters.
  • Pacific Capital Wealth Advisors's Traws Pharma position peaked at $29 in Q2 2024.
  • 19 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2025.

Based on Pacific Capital Wealth Advisors's 13F filing for Q1 2025, filed 18 Apr 2025.